NEULANDLABNSENeuland Laboratories Limited· PharmaceuticalsHighNeutral
Announced Fri, 7 Nov · 16:16 IST

Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2025

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Neuland Laboratories has released its unaudited financial results for the second quarter and first half of financial year 2025-26, ending September 30, 2025. This is a routine quarterly disclosure that listed companies on NSE are required to file within 45 days of the quarter end. The detailed results, including revenue, expenses, operating profit, tax, and profit after tax figures, would be contained in the accompanying PDF. Note: the actual numerical content of the filing was not provided in the source text, so specific figures cannot be verified from this announcement alone.

Likely market impact

Quarterly results typically influence short-term stock movement based on whether reported revenue and profit beat or miss market expectations. Shareholders should compare the detailed numbers against prior periods and analyst estimates. Without the actual figures here, no directional impact on share price can be inferred from this headline alone.